Hypertension and the pregnancy complicated by diabetes

Current Diabetes Reports

Volumn 6, Issue 4, 2006, Pages 297-304

  Leguizamón, Gustavo F ^a   Zeff, Natalia P ^b   Fernández, Alberto ^b  

^a CEMIC   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; GLUCOSE; INSULIN; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN; THROMBOXANE;

CAUCASIAN; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MATERNAL HYPERTENSION; MORTALITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PROTEIN SYNTHESIS INHIBITION; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 33748335386     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-006-0064-1     Document Type: Review

References (47)

1. Conquering Diabetes. A Strategic Plan for the 21st Century. A report of the congressionally established diabetes research working group 1999. NIH publication No. 99-4398. http://www.niddk.nih.gov/federal/dwg/fr.pdf.
2. ACOG Committee on Practice Bulletins: ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol 2005, 105:675-685.
3. American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 2004, 27(suppl 1):S88-S90.
4. Brody SC, Harris R, Lohr K: Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003, 101:380-392.
5. Bernasko J: Contemporary management of type 1 diabetes mellitus in pregnancy. Obstet Gynecol Surv 2004, 59:628-636.
6. Hiilesmaa V, Suhonen L, Teramo K: Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 2000, 43:1534-1539.
7. Hanson U, Persson B: Epidemiology of pregnancy-induced hypertension and preeclampsia in type I (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 1998, 77:620-624.
8. Miodovnik M, Rosenn BM, Khoury JC, et al.: Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol 1996, 74:1180-1189; discussion 1189-1191.
9. Sibai BM, Caritis S, Hauth J, et al.: Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000, 182:364-369.
10. Combs CA, Rosenn B, Kitzmiller JL, et al.: Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 1993, 82:802-807.
11. Reece EA, Coustan DR, Hayslett, et al.: Diabetic nephropathy: pregnancy performance and fetomaternal outcomes. Am J Obstet Gynecol 1988, 159:56-66.
12. Kimmerle R, Zass RP: Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995, 38:227-23S.
13. Gordon M, Landon MB, Samuels P, et al.: Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996, 87:401-409.
14. Reece EA, Leguizamon G, Homko C: Pregnancy performance and outcomes associated with diabetic nephropathy. Am J Perinatol 1998, 15:413-421.
15. Sibai BM: Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern Fetal Med 2000, 9:62-65.
16. Cousins L: Obstetric complications in diabetic pregnancies. In Diabetes in Women. Adolescence, Pregnancy, and Menopause. Edited by Reece EA, et al. Philadelphia: Lippincott, Williams, & Wilkins; 2004:351-362.
17. Cousins LM: Pregnancy complications among diabetic women: review 1965-1985. Obstet Gynecol Surv 1987, 42:140-147.
18. Garner PR, D'Alton ME, Dudley DK, et al.: Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990, 163:505-508.
19. Siddiqi T, Rosenn B, Mimouni F, et al.: Hypertension during pregnancy in insulin-dependent diabetic women. Obstet Gynecol 1991, 77:514-519.
20. Rudge M, Calderon I, Ramos M, et al.: Hypertensive disorders in pregnant women with diabetes mellitus. Gynecol Obstet Invest 1997, 44:11-15.
21. Cundy T, Slee F, Gamble G, et al.: Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes. Diabet Med 2002, 19:482-489.
22. Leguizamon G, Reece EA: Effect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes and hypertension. J Matern Fetal Med 2000, 9:70-78.
23. Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999, 341:1127-1133.
24. Kitzmiller JL, Brown ER, Phillippe M, et al.: Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 1981, 141:741-751.
25. Reece EA, Leguizamon GF, Homko C: Stringent controls in diabetic nephropathy associated with optimisation of pregnancy outcomes. J Matern Fetal Med 1998, 7:213-216.
26. Ekbom P, Damm P, Feldt-Rasmussen B, et al.: Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001, 24:1739-1744.
27. How HY, Sibai B, Lindheimer M, et al.: Is early-prepancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus? Am J Obstet Gynecol 2004, 190:775-778.
28. Hsu CD, Hong SF, Nickless NA, Copel JA: Glycosylated hemoglobin in insulin-dependent diabetes mellitus related to preeclampsia. Am J Perinatol 1998, 15:199-202.
29. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996, 3:179-84.
30. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
31. Arauz-Pacheco C, Parrott MA, Raskin P: Treatment of hypertension in adults with diabetes. Diabetes Care 2003, 26(supp 1): S80-S82.
32. Caritis S, Sibai B, Hauth J, et al.: Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1998, 179:946-951.
33. Duckitt K, Harrington D: Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005, 330:565.
34. Lauszus FF, Rasmussen OW, Lousen T, et al.: Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation. Acta Obstet Gynecol Scand 2001, 80:1096-1103.
35. Ekbom P, Damm P, Nogaard K, et al.: Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in type I diabetes. Diabetologia 2000, 43:927-931.
36. Vambergue A, Nuttens MC, Goeusse P, et al.: Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. Eur J Obstet Gynecol Reprod Biol 2002, 102:31-35.
37. Joffe GM, Esterlitz JR, Levine RJ, et al.: The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998, 179:1032-1037.
38. Casey BM, Lucas MJ, MCIntire DD, et al.: Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997, 90:869-873.
39. Jensen DM, Sorensen B, Feilberg-Jorgensen N, et al.: Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med 2000, 17:281-286.
40. Schaffir JA, Lockwood CJ, Lapinski R, et al.: Incidence of pregnancy-induced hypertension among gestational diabetics. Am J Perinatol 1995, 12:252-254.
41. Sermer M, Naylor CD, Gare DJ, et al.: Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995, 173:146-156.
42. Yogev Y, Xenakis EMJ, Langer O: The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 2004, 191:1655-1660.
43. Caritis S, Sibai B, Hauth J, et al.: Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, 338:701-705.
44. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnancy women. CLASP Collaborative Low Dose Aspirin Study in Pregnancy Collaborative Group [no authors listed]. Lancet 1994, 343:619-629.
45. Coomarasamy A, Honest H, Papaioanno S, et al.: Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003, 101:1319-1332.
46. Roberts JM, Gammill HS: Preeclmapsia: recent insights. Hypertension 2005, 46:1243-1249.
47. Poston L, Brilley AL, Kelly FJ, et al.: Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Available online at http://www.thelancet.com. Accessed March 30, 2006.